Literature DB >> 99221

Cellular immunity and nutrition in refractory disseminated blastomycosis.

R B FitzSimons, A C Ferguson.   

Abstract

In a previously healthy 13-year-old girl with disseminated blastomycosis, immunodeficiency was considered because of lymphopenia and the slow response of her lung disease to therapy with amphotericin B. Cellular immunity was found to be profoundly impaired, with absent delayed cutaneous hypersensitivity to several common antigens, a decreased count of thymus-dependent lymphocytes in the peripheral blood and a greatly diminished in-vitro proliferative response of lymphocytes to phytohemagglutinin (PHA). Humoral immunity was intact. Two additional types of therapy were assessed: subcutaneous injection of transfer factor was associated with an unsustained increase in lymphocyte counts and a positive cutaneous response to PHA but no clinical change; parenteral alimentation to ensure an adequate energy intake was associated with rapid clinical improvement, the development of delayed hypersensitivity to four additional antigens, and the return of lymphocyte counts and proliferative response to normal. These findings suggest that increased energy intake rather than transfer factor therapy was responsible for the child's recovery, and they emphasize the importance of adequate nutrition in the maintenance of intact cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99221      PMCID: PMC1818335     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

Review 1.  Opportunistic infection in children. II. In the compromised host.

Authors:  R D Feigin; W T Shearer
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

2.  Editorial: Measurement of delayed skin-test responses.

Authors:  J E Sokal
Journal:  N Engl J Med       Date:  1975-09-04       Impact factor: 91.245

3.  [North American blastomycosis in Canada. (Findings on all published and unpublished cases and results obtained in 4 cases treated with amphotericin B)].

Authors:  J GRANDBOIS
Journal:  Laval Med       Date:  1963-06

Review 4.  Chemotherapy of systemic mycoses (first of two parts).

Authors:  J E Bennett
Journal:  N Engl J Med       Date:  1974-01-03       Impact factor: 91.245

5.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

6.  Routine application of the nitroblue tetrazolium test in the clinical laboratory.

Authors:  A M Gordon; R M Rowan; T Brown; H G Carson
Journal:  J Clin Pathol       Date:  1973-01       Impact factor: 3.411

Review 7.  Transfer factor.

Authors:  H S Lawrence
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

8.  Properties and activities of transfer factor.

Authors:  C H Kirkpatrick
Journal:  J Allergy Clin Immunol       Date:  1975-06       Impact factor: 10.793

Review 9.  Infection, anergy and cell-mediated immunity.

Authors:  F S Kantor
Journal:  N Engl J Med       Date:  1975-03-20       Impact factor: 91.245

10.  Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation.

Authors:  A C Ferguson; G J Lawlor; C G Neumann; W Oh; E R Stiehm
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

View more
  1 in total

1.  Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis.

Authors:  G S Deepe; C L Taylor; W E Bullock
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.